Redirect Notice
The previous page is sending you to
https://pharmashots.com/1251/leo-pharma-enters-into-a-sub-licensing-agreement-with-bausch-health-to-develop-and-commercialize-brodalumab-for-moderate-to-severe-psoriasis-outside-europe
.
If you do not want to visit that page, you can
return to the previous page
.